Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrari

Showing results (471-480 of 547) with videos related to

Pageof 55
Sort By:
International Journal of Cardiology|June 11, 2019
Trimetazidine in cardiovascular medicineMario Marzilli, Dragos Vinereanu, Gary Lopaschuk, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsMarco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
Blood|February 13, 2009
Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasisChristos Gekas, Katrin E Rhodes, Laurraine M Gereige, et al.
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Journal of Medicinal Chemistry|August 1, 2018
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F<sub>1</sub>/F<sub>O</sub>-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial InfarctionGiampaolo Morciano, Delia Preti, Gaia Pedriali, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 2, 2021
The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studiesAndrea Erriquez, Rita Pavasini, Simone Biscaglia, et al.
European Journal of Heart Failure|May 21, 2016
Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of CardiologyBarak Zafrir, Nabeeh Salman, Maria G Crespo-Leiro, et al.
European Journal of Heart Failure|October 30, 2016
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term RegistryGiovanni Targher, Marco Dauriz, Cécile Laroche, et al.
The EMBO Journal|April 2, 2024
LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cellsJulieta Ramírez-Cuéllar, Roberto Ferrari, Rosario T Sanz, et al.
European Heart Journal|September 11, 2019
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registryEmmanuel Sorbets, Kim M Fox, Yedid Elbez, et al.
Pageof 55

Showing results (471-480 of 547) with videos related to

Sort By:
Pageof 55
International Journal of Cardiology|June 11, 2019
Trimetazidine in cardiovascular medicineMario Marzilli, Dragos Vinereanu, Gary Lopaschuk, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsMarco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
Blood|February 13, 2009
Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasisChristos Gekas, Katrin E Rhodes, Laurraine M Gereige, et al.
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Journal of Medicinal Chemistry|August 1, 2018
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F<sub>1</sub>/F<sub>O</sub>-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial InfarctionGiampaolo Morciano, Delia Preti, Gaia Pedriali, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 2, 2021
The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studiesAndrea Erriquez, Rita Pavasini, Simone Biscaglia, et al.
European Journal of Heart Failure|May 21, 2016
Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of CardiologyBarak Zafrir, Nabeeh Salman, Maria G Crespo-Leiro, et al.
European Journal of Heart Failure|October 30, 2016
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term RegistryGiovanni Targher, Marco Dauriz, Cécile Laroche, et al.
The EMBO Journal|April 2, 2024
LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cellsJulieta Ramírez-Cuéllar, Roberto Ferrari, Rosario T Sanz, et al.
European Heart Journal|September 11, 2019
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registryEmmanuel Sorbets, Kim M Fox, Yedid Elbez, et al.
Pageof 55